ResearcherLanzhou UniversityActive in the last 2 years
Zhisheng Qiu
Matched on OpenAlex author ID A5065480558. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- Interleukin-1α (IL-1α) in pancreatic ductal adenocarcinoma: implications for immunotherapy and molecular biomarkers. Last author DOI 10.1007/s12094-026-04325-5↗
- DEAD/H-box RNA helicase 10 promotes pancreatic cancer cell proliferation via ribonucleotide reductase M2. Co-author DOI 10.4251/wjgo.v17.i9.108672↗
- Retraction: miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. Co-author DOI 10.3724/abbs.2024209↗
- miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. Co-author DOI 10.1093/abbs/gmz096↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mingxu Da · 3 shared papers, 2019–2025 · strength 0.75
- Paper Retraction: miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeti… DOI 10.3724/abbs.2024209↗
- Paper DEAD/H-box RNA helicase 10 promotes pancreatic cancer cell proliferation via ribonucleotide reductase M2. DOI 10.4251/wjgo.v17.i9.108672↗
- Paper miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. DOI 10.1093/abbs/gmz096↗
- Ke Ling · 1 shared paper, 2026 · strength 0.39
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.